ARTHEx Biotech
ARTHEx Biotech, a University of Valencia spin-off, develops innovative microRNA-based therapies to address diseases with unmet medical needs.
About ARTHEx Biotech
ARTHEx Biotech S.L., founded in 2019, is a biotechnology spin-off from the University of Valencia, dedicated to developing antisense RNA-based therapies for genetic diseases. The company builds on strong expertise in drug discovery and the role of microRNAs in neuromuscular disorders to create innovative treatment approaches. Supported by internationally renowned scientific and clinical advisors, ARTHEx Biotech aims to successfully translate cutting-edge research into effective therapies addressing unmet medical needs.



